Literature DB >> 7713187

Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions.

O S Levine1, D Vlahov, K E Nelson.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7713187     DOI： 10.1093/oxfordjournals.epirev.a036161

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN： 0193-936X            Impact factor:   6.222


× No keyword cloud information.
  21 in total

1.  Vaccination could improve overall health in a high risk population.

Authors:  H Hagan
Journal:  West J Med       Date:  2000-01

2.  Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

Authors:  J Lorvick; A H Kral; K Seal; L Gee; B R Edlin
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

3.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

4.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

5.  Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.

Authors:  David Widjaja; Suresh Yarlagadda; Bheema S Singu; Raghu S Loganathan; Steve Blum; Alan Bloom; Prospere Remy
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

Review 6.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 7.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

8.  Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Authors:  F Saillour; F Dabis; M Dupon; D Lacoste; P Trimoulet; P Rispal; E Monlun; J M Ragnaud; P Morlat; J L Pellegrin; H Fleury; P Couzigou
Journal:  BMJ       Date:  1996-08-24

9.  Limited infection with occult hepatitis B virus in drug users in the USA.

Authors:  Jason T Blackard; Christina M Martin; Satarupa Sengupta; Janet Forrester
Journal:  Hepatol Res       Date:  2012-08-22       Impact factor: 4.288

10.  Epidemiology of hepatitis B in Canada.

Authors:  J Zhang; S Zou; A Giulivi
Journal:  Can J Infect Dis       Date:  2001-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.